CVS 2010 Annual Report Download - page 53

Download and view the complete annual report

Please find page 53 of the 2010 CVS annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 82

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82

Consolidated Statements of Shareholders’ Equity
Shares Dollars
Year Ended December 31, Year Ended December 31,
in millions 2010 2009 2008 2010 2009 2008
Retained earnings:
Beginning of year $ 16,355 $ 13,098 $ 10,287
Net income (excludes net loss attributable
to noncontrolling interest of $3 in 2010) 3,427 3,696 3,212
Common stock dividends (479) (439) (370)
Preference stock dividends (14)
Tax benefit on preference stock dividends 1
Adoption of ASC 715-60 (formerly EITF 06-04
and 06-10) (18)
End of year $ 19,303 $ 16,355 $ 13,098
Accumulated other comprehensive loss:
Beginning of year $ (135) $ (143) $ (50)
Net cash flow hedges, net of income tax (1) 1 3
Pension liability adjustment, net of income tax (7) 7 (96)
End of year $ (143) $ (135) $ (143)
Total shareholders’ equity $ 37,700 $ 35,768 $ 34,574
Comprehensive income:
Net income $ 3,424 $ 3,696 $ 3,212
Net cash flow hedges, net of income tax (1) 1 3
Pension liability adjustment, net of income tax (7) 7 (96)
Comprehensive income 3,416 3,704 3,119
Comprehensive loss attributable to
noncontrolling interest 3
Comprehensive income attributable to CVS Caremark $ 3,419 $ 3,704 $ 3,119
See accompanying notes to consolidated financial statements.
– 49 –